Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Market Wrap SP 500 posts modest gains as techheavy Nasdaq rises while Dow dips The technology investments behind HeartSciences HSCSW growth HSCSW Q1 Earnings HeartSciences Revenue Data Unavailable TBI TrueBlue Inc shares climb 6 percent despite reporting fourth quarter 2025 earnings far below analyst estimates K Wave KWM Stock Underpriced 376 20260420 What LM Funding LMFA disclosed about liquidity position Q4 2025 Earnings Fall Short Bluerock RE BPRE Stock Valuation Gap Analysis Earnings Report The fundamentals driving Mastech Digital MHH everyone should understand Overhead Buying 20260511 NextEra Energy in Talks to Acquire Dominion Energy in StockHeavy Deal Caesars CZR Q1 2026 Earnings Miss EPS 048 vs 024 Expected AutoState Lawmakers Push to Restrict Chinese Vehicle Imports as Trump Prepares Beijing Visit DENTSPLY SIRONA XRAY Declines 144 Amid Market Weakness 20260518 Ionis Pharmaceuticals IONS Stock Analysis 149 Gain What to Watch 20260519 Marker Therapeutics MRKR Q4 2025 Earnings 009 EPS Surges Past 020 Estimates Surging Gas Prices Disproportionately Strain LowerIncome Households New York Fed Study Finds Forgotten 1989 Gold Heap in Nevada Emerges as Potential NearTerm Antimony Source Amazons Dominance in Western ECommerce Why No Rival Has Closed the Gap JDcom Founder Pledges Job Protection for 900000 Workers Amid AI Transformation Dekiln Partners with Johnson Tiles to Scale LowCarbon Recycled Tile Production in UK Ceramics Revival Entrata Files for US IPO Reports 23 Revenue Growth Backed by Silver Lake Coffee Holding Co Inc JVA Q4 2019 Earnings EPS Misses Estimates by Wide Margin Amid Ongoing Industry Challenges AVBH Q1 2026 Earnings EPS Surpasses Estimates by 275 Stock Slightly Declines Apollo Global Management APO Q1 2026 Earnings EPS Misses by 05 Amid Mixed Market Signals Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline ACIU Q1 2026 Earnings Narrower Net Loss Highlights Cost Discipline in PreRevenue Phase Coty Inc COTY Holds Steady at 203 as Stock Tests Key Support and Resistance Levels Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344 SAP ADS SAP Edges Higher Amidst Steady Support Levels Treace Medical Concepts TMCI Advances 397 as Stock Tests Key Resistance at 317 KLX Energy Services KLXE Edges Higher as Support Holds Near 294